Pharma-Bio Serv (OTCMKTS:PBSV) Posts Quarterly Earnings Results, Beats Expectations By $1.41 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) released its quarterly earnings data on Tuesday. The company reported $1.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $1.41, reports. The business had revenue of $2.30 million during the quarter, compared to analysts’ expectations of $2.70 million. Pharma-Bio Serv had a negative net margin of 1.11% and a negative return on equity of 0.83%.

Pharma-Bio Serv Stock Performance

OTCMKTS PBSV opened at $0.48 on Wednesday. The firm’s fifty day moving average price is $0.54 and its two-hundred day moving average price is $0.57. The stock has a market cap of $10.99 million, a PE ratio of -48.00 and a beta of 0.68. Pharma-Bio Serv has a fifty-two week low of $0.35 and a fifty-two week high of $1.36.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.